Robert Howard
University College London
H-index: 97
Europe-United Kingdom
Top articles of Robert Howard
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life | European Journal of Neurology | Anju D Keetharuth Rebecca L Gould Christopher J McDermott Benjamin J Thompson Charlotte Rawlinson | 2024/4/25 |
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial | Alzheimer's & Dementia | Robert Howard Elizabeth Cort Charlotte Rawlinson Martin Wiegand Anne Downey | 2024/3/13 |
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled … | The Lancet | RL Gould CJ McDermott BJ Thompson CV Rawlinson M Bursnall | 2024/3/12 |
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study | Neurology | Matthew Adesuyan Yogini H Jani Dana Alsugeir Robert Howard Chengsheng Ju | 2024/2/27 |
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status | British Journal of Clinical Pharmacology | Suzanne Reeves Julie Bertrand Stephen John Obee Samora Hunter Robert Howard | 2024/1 |
Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer’s disease: a narrative review | Jemma Hazan Kathy Y Liu Nick C Fox Robert Howard | 2023 | |
Lecanemab trial in AD brings hope but requires greater clarity | Madhav Thambisetty Robert Howard | 2023/3 | |
Lecanemab and APOE Genotyping in Clinical Practice—Navigating Uncharted Terrain | JAMA neurology | Madhav Thambisetty Robert Howard | 2023/5/1 |
Association Between False Memories and Delusions in Alzheimer Disease | JAMA psychiatry | Emma McLachlan Dilek Ocal Neil Burgess Suzanne Reeves Robert Howard | 2023/7/1 |
New treatments for Alzheimer’s disease | Robert Howard Helen C Kales Joe P Tupin | 2023/8/22 | |
Clinical effectiveness of the NIDUS randomised control trial of a tailored, goal‐focused intervention for increasing goal attainment in people living with dementia and their … | Alzheimer's & Dementia | Jessica Budgett Julie Barber Rachael M Hunter Penny Rapaport Kathryn Lord | 2023/12 |
Heart rate variability and risk of agitation in Alzheimer’s disease: the Atherosclerosis Risk in Communities Study | Brain Communications | Kathy Y Liu Eric A Whitsel Gerardo Heiss Priya Palta Suzanne Reeves | 2023 |
How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful? | Alzheimer's & Dementia | Kathy Y Liu Madhav Thambisetty Robert Howard | 2023/3 |
Feasibility randomised controlled trial of online group Acceptance and Commitment Therapy for Functional Cognitive Disorder (ACT4FCD) | BMJ open | Norman Poole Sarah Cope Serena Vanzan Aimee Duffus Nadia Mantovani | 2023/5/1 |
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring | British Journal of Clinical Pharmacology | Matthew Roughley Carlos Mena Robert Howard Suzanne Reeves Julie Bertrand | 2023/7 |
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression | Sameer Jauhar Danilo Arnone David S Baldwin Michael Bloomfield Michael Browning | 2023/8 | |
Evaluation of clinical benefits of treatments for Alzheimer's disease | Kathy Y Liu Sebastian Walsh Carol Brayne Richard Merrick Edo Richard | 2023/11/1 | |
Protocol: Feasibility randomised controlled trial of online group Acceptance and Commitment Therapy for Functional Cognitive Disorder (ACT4FCD) | BMJ Open | Norman Poole Sarah Cope Serena Vanzan Aimee Duffus Nadia Mantovani | 2023 |
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance | Harry Costello Jonathan P Roiser Robert Howard | 2023/2 | |
Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART | Alzheimer's & Dementia | Alexander J Ehrenberg Michael A Kelberman Kathy Y Liu Martin J Dahl David Weinshenker | 2023/5 |
